MODULATION OF CD40 EXPRESSION

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP08852011.9

公开号：

EP2222851B1

申请日:

2008.11.20

申请国别(地区):

EP

年份:

2017

代理人:

摘要：

Disclosed herein are antisense compounds and methods for decreasing CD40. Examples of disease conditions that can be ameliorated with the administration of antisense compounds targeted to CD40 include hyperproliferative disorders, graft versus host disease (GVHD), graft rejection, asthma, airway hyperresponsiveness, chronic obstructive pulmonary disease (COPD), multiple sclerosis (MS), systemic lupus erythematosus (SLE), and certain forms of arthritis.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/